Robert Horn

Reducing the Cost of Antimicrobial Resistance

Allan Coukell, Ella Balasa, Nick Crabb, Mark Feinberg, Jeremy Knox, Jenelle Krishnamoorthy, Alan Kockel, John Rigg, Robert Horn

This event convened global health experts to address the critical economic barriers and market failures preventing the development of new antimicrobials amidst rising resistance. Panelists highlighted the urgent need for innovative pull incentives, such as the UK's subscription model, to replace volume-based revenue while emphasizing that stewardship and rapid diagnostics are essential to preserve drug efficacy. The consensus called for immediate policy action to align public, private, and philanthropic resources across G20 nations to sustain the antibiotic innovation ecosystem before the window of opportunity closes.